PTEN Up-Regulates the Tumor Metastasis Suppressor Gene Drg-1 in Prostate and Breast Cancer
暂无分享,去创建一个
Ying Wang | Therese Commes | David Piquemal | Kounosuke Watabe | Sucharita Bandyopadhyay | K. Miura | Ken Saito | M. Watabe | S. Hirota | S. Hosobe | K. Watabe | Ying Wang | T. Commes | S. K. Pai | D. Piquemal | Jodi Huggenvik | Sudha K Pai | Misako Watabe | Shigeru Hirota | Sadahiro Hosobe | Taisei Tsukada | Kunio Miura | Ken Saito | Sudha K. Pai | J. Huggenvik | S. Bandyopadhyay | Y. Takano | Yukio Takano | Steven Gross | S. Gross | T. Tsukada | Kunio Miura | Sucharita Bandyopadhyay | Yuki Takano
[1] C. Bucana,et al. Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] A. Hall,et al. Regulation of Cell Migration by the C2 Domain of the Tumor Suppressor PTEN , 2004, Science.
[3] Ken Saito,et al. Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression , 2004, Oncogene.
[4] W. Isaacs,et al. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. , 1998, Cancer research.
[5] B. Karlan,et al. Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. , 2003, Cancer research.
[6] B. Howard,et al. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells , 1982, Molecular and cellular biology.
[7] M. Oshimura,et al. Localization of metastasis suppressor gene(s) for rat prostatic cancer to the long arm of human chromosome 10 , 1995, Genes, chromosomes & cancer.
[8] J. Roth,et al. PI3 kinase blockade by Ad-PTEN inhibits invasion and induces apoptosis in RGP and metastatic melanoma cells. , 2002, Molecular medicine.
[9] W. Dinjens,et al. A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[10] S. Aaronson,et al. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. , 1998, Cancer research.
[11] C. Cordon-Cardo,et al. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[12] Yusuke Nakamura,et al. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway , 2001, Oncogene.
[13] H. Yi,et al. Suppression of tumorigenicity and metastasis in B16F10 cells by PTEN/MMAC1/TEP1 gene. , 2001, Cancer letters.
[14] X. Wu,et al. The phosphatidylinositol‐3 kinase pathway regulates bladder cancer cell invasion , 2004, BJU international.
[15] T. Lin,et al. Cloning and characterization of TDD5, an androgen target gene that is differentially repressed by testosterone and dihydrotestosterone. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[16] K. Miura,et al. The Drg-1 gene suppresses tumor metastasis in prostate cancer. , 2003, Cancer research.
[17] P. Nelson,et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. , 2003, Cancer cell.
[18] T. Mak,et al. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. , 2000, Cancer research.
[19] H. Ford,et al. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. , 2000, Cancer research.
[20] Mitsuaki Suzuki,et al. PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy , 2002, International journal of cancer.
[21] J. Roth,et al. PI3K Blockade by Ad-PTEN Inhibits Invasion and Induces Apoptosis in Radial Growth Phase and Metastatic Melanoma Cells , 2002 .
[22] L. Cantley,et al. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[23] J. Swinnen,et al. The differentiation‐related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells , 1999, FEBS letters.
[24] P. Pandolfi,et al. Pten Dose Dictates Cancer Progression in the Prostate , 2003, PLoS biology.
[25] T. Liu,et al. Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN , 2001, Oncogene.
[26] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[27] D. Troyer,et al. Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[28] P. Dahia,et al. PTEN, a unique tumor suppressor gene. , 2000, Endocrine-related cancer.
[29] P. Depowski,et al. Loss of Expression of the PTEN Gene Protein Product Is Associated with Poor Outcome in Breast Cancer , 2001, Modern Pathology.
[30] C. Sawyers,et al. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.